Nuformix plc (LON:NFX – Get Free Report) was up 4.4% during trading on Friday . The company traded as high as GBX 0.14 and last traded at GBX 0.14. Approximately 20,339,689 shares traded hands during mid-day trading, a decline of 32% from the average session volume of 29,953,295 shares. The stock had previously closed at GBX 0.14.
Nuformix Stock Up 4.4%
The stock has a market capitalization of £3.68 million, a price-to-earnings ratio of -4.81 and a beta of 1.52. The business’s 50 day simple moving average is GBX 0.17 and its 200-day simple moving average is GBX 0.19.
Nuformix (LON:NFX – Get Free Report) last issued its quarterly earnings results on Thursday, May 28th. The company reported GBX (0.02) earnings per share for the quarter.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.
Featured Articles
- Five stocks we like better than Nuformix
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
